2023
The effect of duration of untreated psychosis (DUP) on the risk for hospitalization after admission to a first episode service
Ferrara M, Guloksuz S, Hazan H, Li F, Tek C, Sykes L, Riley S, Keshavan M, Srihari V. The effect of duration of untreated psychosis (DUP) on the risk for hospitalization after admission to a first episode service. Schizophrenia Research 2023, 260: 198-204. PMID: 37688984, DOI: 10.1016/j.schres.2023.08.005.Peer-Reviewed Original ResearchConceptsFirst-episode psychosis servicesLength of stayUntreated psychosisPsychiatric hospitalizationFirst-episode servicesDuration of hospitalizationIncidence rate ratiosNon-affective psychosisNew Haven areaPoisson regression modelsPatient characteristicsHospitalization ratesRecent onsetMedical recordsHospitalizationEffect of durationNegative binomial regressionSpecialized treatmentPsychosisRate ratioBinomial regressionAdmissionDUPEnrollmentFirst year
1993
Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection
Herskowitz A, Vlahov D, Willoughby S, Chaisson R, Schulman S, Neumann D, Baughman K. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. The American Journal Of Cardiology 1993, 71: 955-958. PMID: 8465788, DOI: 10.1016/0002-9149(93)90913-w.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusCongestive heart failureLeft ventricular dysfunctionLV dysfunctionHeart failureVentricular dysfunctionConsecutive human immunodeficiency virusSymptomatic congestive heart failureHuman immunodeficiency virus (HIV) infectionCardiac contractile abnormalitiesHIV clinic populationLow CD4 countImmunodeficiency virus infectionClinical heart diseaseCD4 countHIV clinicHIV infectionContractile abnormalitiesImmunodeficiency virusRecent onsetClinic populationHeart diseaseCrude rateVirus infectionPatients
1990
ASSOCIATION OF DRUG INJECTION PATTERNS WITH ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AMONG INTRAVENOUS DRUG USERS IN BALTIMORE, MARYLAND
VLAHOV D, MUñOZ A, ANTHONY J, COHN S, CELENTANO D, NELSON K. ASSOCIATION OF DRUG INJECTION PATTERNS WITH ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AMONG INTRAVENOUS DRUG USERS IN BALTIMORE, MARYLAND. American Journal Of Epidemiology 1990, 132: 847-856. PMID: 2239899, DOI: 10.1093/oxfordjournals.aje.a115727.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virus type 1Immunodeficiency virus type 1HIV-1 seroprevalenceVirus type 1Drug usersInjection careerShooting galleriesType 1Drug injection patternsHIV-1 serostatusHIV-1 infectionRecent onsetDrug injectionHigh riskCommunity outreach effortsDrug useGallery useSame calendar yearSex practicesSeroprevalenceCalendar yearPersistent useAntibodiesPersistent sharing
1989
Early image acquisition after administration of indium-111 platelets in clinically suspected deep venous thrombosis
Farlow D, Ezekowitz M, Rao S, Martinez C, Denny D, Morse S, Decho J, Wackers F, Strauss E. Early image acquisition after administration of indium-111 platelets in clinically suspected deep venous thrombosis. The American Journal Of Cardiology 1989, 64: 363-368. PMID: 2502903, DOI: 10.1016/0002-9149(89)90536-5.Peer-Reviewed Original ResearchConceptsDeep venous thrombosisVenous thrombosisPlatelet scintigraphyEarly imagingAsymptomatic high-risk patientsSymptomatic deep venous thrombosisAcute deep venous thrombosisIndium-111 platelet scintigraphyHigh-risk patientsIndium-111 plateletsEarly image acquisitionIndium-111 oxinePlatelet injectionPlatelet scanAnticoagulated patientsSymptomatic patientsContrast venographyRecent onsetTimely institutionIntravenous administrationScintigraphyBlinded observersPatientsThrombosisLow sensitivity
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply